FDA Transparency Team Fields 900 Comments And Counting For Final Report
This article was originally published in The Gray Sheet
Executive Summary
FDA is wading through more than 900 comments on its new transparency initiative and, in an odd twist for an agency already inundated with busywork, staffers say: "keep the suggestions coming.
You may also be interested in...
FDA Aims To Explain Itself Better With New Transparency Task Force
FDA's newly formed transparency task force will try to identify more effective ways to explain controversial agency decisions to the public
FDA Diagnostics Office Seeks Bigger Role In Personalized Medicine
FDA officials that regulate lab tests don't think they have been active enough in the policy debate over the future of personalized medicine; but, they say, that is about to change
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”